Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-820-0 | CAS number: 74-89-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- chronic toxicity: inhalation
- Remarks:
- other: subacute and chronic
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: acceptable well-documented publication, which meets basic scientific principles
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- publication
- Title:
- Comparative toxicity of methyl isocyanate and its hydrolytic derivatives in rats
- Author:
- Sriramachari S., Jeevaratnam K.
- Year:
- 1 994
- Bibliographic source:
- Arch Toxicol 69: 45-51 (1994)
Materials and methods
- Principles of method if other than guideline:
- Long-term (subacute and chronic) histopathological effects in the lungs of rats subjected to a single exposure to methyl isocyanate (MIC) by both the inhalation and subcutaneous (s.c.) routes as well as the role of methylamine (MA) and N,N'-dimethylurea (DMU), the hydrolytic derivatives of MIC in eliciting the observed changes.
- GLP compliance:
- no
- Limit test:
- yes
Test material
- Reference substance name:
- Methylamine
- EC Number:
- 200-820-0
- EC Name:
- Methylamine
- Cas Number:
- 74-89-5
- Molecular formula:
- CH5N
- IUPAC Name:
- methanamine
- Details on test material:
- - Name of test material (as cited in study report): methylamine
Constituent 1
Test animals
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- no data
Administration / exposure
- Route of administration:
- other: inhalation and subcutaneous application
- Type of inhalation exposure:
- not specified
- Vehicle:
- not specified
- Remarks on MMAD:
- MMAD / GSD: no data
- Details on inhalation exposure:
- For MA by the inhalation route for each period of study, four rats were exposed to 19 µmol/L (~1.0 LC50 MIC in terms of mol).
In addition, either MA or DMU at 5.75 mmol/kg was injected s.c. into a group of four rats each for each period of the study. - Analytical verification of doses or concentrations:
- no
- Details on analytical verification of doses or concentrations:
- no data
- Duration of treatment / exposure:
- no data
- Frequency of treatment:
- no data
Doses / concentrationsopen allclose all
- Dose / conc.:
- 19 other: µmol/L
- Remarks:
- Basis: nominal conc.
- Dose / conc.:
- 5.75 other: µmol/L (s.c.)
- No. of animals per sex per dose:
- 4
- Control animals:
- yes
- Details on study design:
- In the corresponding control groups for each duration of study, four rats each were subjected to either the inhalation procedure without the test material or s.c. administration of the vehicle, olive oil.
Examinations
- Observations and examinations performed and frequency:
- The appearance and behavior of animals exposed to MIC and its hydrolytic derivatives have already been described in the preceding paper (Jeevaratnam and Sriramachari 1994). Nearly similar findings were found in all the rats after the exposure to varied concentrations of MIC. The animals continued to be moribund and scarcely consuming any feed or water. After 2 or 3 days, the general condition of the animals improved and they were moving about, Although many of them exhibited the signs and symptoms of acute respiratory distress syndrome (ARDS) up to 4 weeks, there was a gradual improvement in ARDS beyond 4 weeks. Thereafter, the animals were apparently normal without any signs of underlying gross pathology of the lung.
- Sacrifice and pathology:
- Only a group of four rats of those that survived were killed at the end of each duration of the experiment by cervical dislocation. They were subjected to post-mortem examination.
- Other examinations:
- Although all the viscera were removed at autopsy and fixed in 10% neutral formalin, only the histopathological changes of the lungs are dealt in this communication. The tissues wereb processed through paraffin and stained by H&E, PAS, reticulin (silver) and collagen (tfichrome) using standard procedures.
- Statistics:
- no data
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- see in examinations
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- see in examinations
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- bronchial lumen and the epithelial lining were apparently normal in both the MA groups, peculiar and extensive edema in rats exposed to MA via inhalation
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- see in details
- Details on results:
- Methylamine: at all periods of the study, the bronchial lumen and the epithelial lining were apparently normal in both the MA groups.
A peculiar and extensive edema was observed at the end of 1 week in rats exposed to MA vapors through inhalation route. The lungs were uniformly pale and had a washed out appearance. Histologically, lung parenchyma was filled with transparent clear aqueous fluid with the widespread separation of tissue spaces. Thus, the mucosal lining was lifted off the submucosa. Similarly, the perivascular areas were filled with clear edematous fluid extending throughout the pulmonary interstitium and alveoli. This phenomenon was seen to extend into the walls of blood vessels whose adventitial muscular coats were widely separated (Fig. 10). The faintly PAS positive reaction indicated that the fluid is an exudate rather than a transudate.
After 1 week: In both the MA groups, the interstitial spaces showed varying degrees of infiltrates characterized by mononuclear cells and histiocytes without any foamy cells. The connective tissue fibers were sparse and inconspicuous as revealed by both the silver and trichrome preparation.
After 4 weeks: A moderate to severe interstitial pneumonitis without edema was noticed in lungs of rats exposed to MA by either route, the severity being more pronounced in the subcutaneous route of exposure. The reticulin staining showed moderately severe fibrillogenesis in the highly cellular interstitial septa.
After 10 weeks: In both the groups, the lung showed severe interstitial pneumonitis extending into peribronchial and perivascular areas (Fig. 12a). The silver preparation showed abundance of collagen fibers in the corresponding areas (Fig. 12b). By comparison, the intensity of the above lesions is less in MA treated rats than in the MIC treated rats.
Effect levels
- Dose descriptor:
- NOAEC
- Basis for effect level:
- other: one dose level tested; severe interstitial pneumonitis
- Remarks on result:
- not determinable
- Remarks:
- no NOAEC identified
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- MA causes pumonary edema 1 week after expose to MA by inhalation.
MA causes interstitial pneumonitis progressing to fibrosis. - Executive summary:
Sriramachari et al. performed in 1994 a subacute and chronic test in rats with monomethylamine by the route of inhalation or subcutaneous administration. The test duration was 4 weeks; the substance was administered at concentrations of 19 µmole or 5.75 mmol/kg respectively. The animals showed a treatment-induced accumulation of hemorrhagic fluid in the pleural cavity. Histological examination revealed a severe interstitial pneumonitis and fibrosis.
At the subacute phase, the intraalveolar and interstitial edema were prominent only in the inhalation group as against the more pronounced inflammatory response in the s.c. route. With the progress of time the evolution of lesions appeared to be similar, culminating in the development of significant interstitial pneumonitis and fibrosis. MA, one of the hydrolytic derivatives of MIC, also caused interstitial pneumonitis progressing to fibrosis, albeit to a lesser extent than MIC, indicating its contribution to the long-term pulmonary damage.
Though the mechanisms by which either MIC or MA elicit the observed long-term effects are not known presently, the fact that the lung is the target organ for both MIC and MA, which cause the progressing changes leading to a unified picture of chronic puhnonary fibrosis, merits further consideration.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.